Galenica (XSWX:GALE) Buildings And Improvements: CHF0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSWX:GALE Galenica Ltd XSWX:GALE
80 GF Score
Price CHF82.90
GF Value CHF87.78
Valuation Fairly Valued
! 1 Warning Sign
View Full Analysis

What is Galenica Buildings And Improvements?

Galenica XSWX:GALE -0.24% 80 Buildings And Improvements is CHF0 Mil as of Jun. 2026. GuruFocus rates XSWX:GALE with a GF Score™ of 80/100 and a GF Value™ of CHF87.78 (Fairly Valued). The stock has 1 warning sign investors should review.

Galenica's quarterly buildings and improvements increased from Jun. 2025 (CHF0 Mil) to Dec. 2025 (CHF604 Mil) but then declined from Dec. 2025 (CHF604 Mil) to Jun. 2026 (CHF0 Mil).

Galenica's annual buildings and improvements increased from Dec. 2023 (CHF574 Mil) to Dec. 2024 (CHF587 Mil) and increased from Dec. 2024 (CHF587 Mil) to Dec. 2025 (CHF604 Mil).

Galenica Buildings And Improvements Historical Data

* Premium members only.

The historical data trend for Galenica's Buildings And Improvements can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Galenica Buildings And Improvements Chart

Galenica Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Buildings And Improvements
Get a 7-Day Free Trial Premium Member Only Premium Member Only 513.33 553.93 574.22 586.74 603.95

Galenica Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Buildings And Improvements Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 586.74 0.00 603.95 0.00
XSWX:GALE
80GF Score
Galenica Ltd XSWX:GALE
Buildings And Improvements is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Galenica Buildings And Improvements Calculation

Buildings are typically valued at the time of acquisition or construction.  Broker and architect fees, permits, etc. can be covered within this category.  Building components, such as a roof, are normally recorded separately in an asset register since the value and useful lives of these components equal much less than the building itself.

Building improvements that extend the useful life of a building will fall into the category of “building improvements” and should be capitalized.  Improvements are commonly recorded at acquisition cost.  Building improvement examples include roofing, remodeling, replacements, etc.

What does a Buildings And Improvements of CHF0 Mil mean?
Galenica (XSWX:GALE) has a Buildings And Improvements of CHF0 Mil as of Jun. 2026. Buildings and improvements is the total value of a company's buildings and improvements to them. View historical data on Galenica and its competitors.
Is Galenica's Buildings And Improvements too high?
Galenica's current Buildings And Improvements is CHF0 Mil. Overall, Galenica has a GF Score™ of 80/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Galenica's Buildings And Improvements compare to MCK and COR?
Galenica's Buildings And Improvements of CHF0 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buildings And Improvements for a Medical Distribution company?
A good Buildings And Improvements depends on the Medical Distribution industry context. However, Buildings And Improvements should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buildings And Improvements mean?
A high Buildings And Improvements can signal that a stock is expensive relative to its fundamentals. Buildings and improvements is the total value of a company's buildings and improvements to them. View historical data on Galenica and its competitors. Galenica's current Buildings And Improvements is CHF0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Galenica stock overvalued right now?
Based on GuruFocus' analysis, Galenica (XSWX:GALE) is currently considered Fairly Valued. The stock's GF Value™ is CHF87.78, compared to a current price of CHF82.90 — trading 5.6% below its estimated fair value. The current Buildings And Improvements is CHF0 Mil. Galenica's overall GF Score™ is 80/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buildings And Improvements calculated?
Buildings And Improvements is calculated from a company's financial statements. For Galenica (XSWX:GALE), the current Buildings And Improvements is CHF0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Galenica (XSWX:GALE) Overvalued in 2026?

Based on GuruFocus' analysis, Galenica stock appears to be undervalued. The current stock price of CHF82.90 is trading 5.6% below its estimated GF Value™ of CHF87.78. GuruFocus considers Galenica to be Fairly Valued.

Key valuation signals for XSWX:GALE:

  • Buildings And Improvements: CHF0 Mil
  • GF Value™: CHF87.78 vs. price of CHF82.90 (5.6% below fair value)
  • GF Score™: 80/100 with 1 warning sign

No single metric tells the full story. See the XSWX:GALE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Galenica Business Description

Address Untermattweg 8, Bern, CHE, CH-3027
Galenica Ltd is an integrated healthcare service provider in Switzerland. The business is operated from two segments Products & Care and Logistics & IT. The Products & Care segment comprises the Retail business area with offerings for patients and end customers and the Professionals business area with offerings for business customers and partners in the healthcare sector. The Logistics & IT segment comprises the two sectors Wholesale and Logistics & IT Services. These provide services for all those involved in the healthcare sector - pharmacies, drugstores, doctors, hospitals and care homes, partners, and suppliers. Geographically, it operates in Switzerland and Other Countries.
80GF Score

Get the complete analysis for XSWX:GALE

Buildings And Improvements is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF82.90
Price
CHF87.78
GF Value